Clinical Trial Update: A Study Evulating DA-302168S Tablets in Overweight/Obese Subjects [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating DA-302168S tablets in overweight or obese adults has completed. The update confirms the trial status but does not provide efficacy re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• DA-302168S Tablets

Snippet

Sponsor: Chendu DIAO Pharmaceutical Group CO., LTD. | Conditions: Overweight and Obesity | Phase 1 | Status: COMPLETED